Pyschiatric Disorder

Burnout Syndrome Common in Critical Care Professionals

July 13, 2016

Critical care health care professionals have one of the highest rates of burnout syndrome (BOS), compared to other health care professionals, according to a call-to-action statement published in the American Journal of Respiratory and Critical Care Medicine.

FDA Grants Orphan Drug Status to Narcolepsy Treatment

By July 11, 2016

The Food and Drug Administration (FDA) has granted Orphan Drug designation for mazindol (NLS Pharma) for the treatment of narcolepsy.

Severely Lower Med Adherence in COPD Patients with Depression

By June 24, 2016

For patients with Chronic Obstructive Pulmonary Disease (COPD) and a co-morbidity of depression, adherence to COPD maintenance medication is particularly low.

Evaluating Optimal Therapy for Complicated Grief

By June 21, 2016

Data from the first randomized clinical trial evaluating the efficacy of antidepressants with or without complicated grief psychotherapy for the treatment of complicated grief showed that adding citalopram to complicated grief treatment (CGT) helped treat concurrent depressive symptoms.

Comparing Treatment Interventions in Obsessive-Compulsive Disorder

By June 21, 2016

Combining psychotherapeutic and psychopharmacological interventions is likely to be more efficacious than psychotherapeutic interventions alone for the management of obsessive-compulsive disorder (OCD), a study published in Lancet Psychiatry has shown.

Should Asymptomatic Patients Be Screened for OSA?

June 15, 2016

The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations.

Mylan Launches First Generic Nuvigil

By June 01, 2016

Mylan announced the launch of Armodafinil Tablets, the first generic version of Cephalon's Nuvigil.

Nuplazid Launched for Parkinson's Disease Psychosis

By May 31, 2016

Acadia announced the launch of Nuplazid (pimavanserin) tablets for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

Prenatal Smoking May Up Schizophrenia Risk in Offspring

By May 26, 2016

In the most definitive study to date, cigarette smoking during pregnancy was linked to a greater likelihood of schizophrenia in offspring. Those are the findings of a new long-term study which assessed maternal nicotine exposure (via cotinine levels) during pregnancy.

Study Suggests Antipsychotic Agents May Up MI Risk

By May 16, 2016

Patients taking antipsychotic agents may be at an increased risk of myocardial infarction, based on a review of nine observational studies.

Could Ketamine Be the Key to Reducing Suicidal Ideation in MDD Patients?

By May 11, 2016

Repeated doses of intravenous (IV) ketamine quickly reduced suicidal ideation in pharmacologically treated outpatients with treatment-resistant depression with stable suicidal thoughts, according to a study published in the Journal of Clinical Psychiatry.

FDA: Serious Skin Reaction Linked to Atypical Antipsychotic Drug

By May 10, 2016

Cross-reactivity can also occur with other drugs due to structural similarities.

For ADHD, Behavior Therapy Before Medication, CDC Urges

By May 04, 2016

A Vital Signs report from the Centers for Disease Control and Prevention (CDC) found that among insured children 2-5 years old receiving care for attention deficit hyperactivity disorder (ADHD), medication treatment was more common than the recommended first-line treatment of psychological services.

Comprehensive Study Examines Mindfulness in Reoccurring Depression

April 28, 2016

Mindfulness-based cognitive therapy may help reduce the risk of repeated episodes of depression, according to a study published online in JAMA Psychiatry.

Depression Onset Associated With Androgen Deprivation Tx for Prostate CA

April 13, 2016

Older men who receive androgen deprivation therapy (ADT) for prostate cancer may be at increased risk of developing depression, according to a new.

FDA Not Ready to Approve Brintellix for MDD-Related Cognitive Dysfunction

By March 29, 2016

Takeda and Lundbeck announced that the FDA has issued a complete response letter for the sNDA regarding the addition of new clinical trial data to the Brintellix (vortioxetine) labeling for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).

Encenicline Phase 3 Results in Schizophrenia Announced

By March 28, 2016

Forum Pharmaceuticals announced topline results from two Phase 3 clinical trials evaluating encenicline (FRM-6124) in patients with cognitive impairment in schizophrenia (CIS).

Risks of Developing Type 2 Diabetes May be Greater for Teens With Autism

March 28, 2016

Adolescents and young adults with autism spectrum disorder (ASD) are more likely to develop type 2 diabetes mellitus (T2DM), according to a study published online in Diabetes Care.

Depression Care Management Processes Severely Lacking

March 14, 2016

U.S. primary care practices use less than one care management process for depression, on average, according to a study published in the March issue of Health Affairs.

Aristada Under Investigation for 2-Month Dosing Interval in PK Study

By February 26, 2016

Alkermes announced positive top-line results from its pharmacokinetics trial of Aristada (aripiprazole lauroxil extended-release injectable suspension).

Can Acupressure Help With Postpartum Insomnia? Study Results

February 09, 2016

Auricular acupressure is an effective alternative complementary therapy for postpartum women with insomnia, according to a study published in the issue of the Journal of Clinical Nursing.

Is Childhood ADHD an Indicator of Obesity in Adulthood?

February 08, 2016

Childhood attention-deficit/hyperactivity disorder (ADHD) is associated with increased obesity in females, according to a study published online in the Mayo Clinic Proceedings.

Study Compares Efficacy of Two Body Dysmorphic Disorder Treatments

February 04, 2016

Therapist-guided, Internet-based cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD-NET) is superior to online supportive therapy, according to a study published online February 2 in The BMJ.